Other
Hemodialysis
0
Pipeline Programs↗
11
Active Trials↗
18
Companies Involved↗
Hemodialysis is an early-stage landscape with 0 programs across 18 companies. The most active players are Roche, Sanofi, Pathalys Pharma.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
107
clinical trials
Completed70 · 65%
Unknown status14 · 13%
Terminated7 · 7%
Withdrawn5 · 5%
Recruiting5 · 5%
Not yet recruiting3 · 3%
Other3 · 3%
Clinical Trials
Trial Activity
107 trials
Effect of Zinc Supplementation on Hyperhomocysteinemia Compared to Folic Acid in CKD Patient on Hemodialysis
Recruiting·—·N/A·NCT06847139·90 enrolled
Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
Recruiting·—·Phase 2·NCT05498181·100 enrolled
Effects of Self-Management Program on Interdialytic Weight Gain Control in Hemodialysis Patients: A Randomized Controlled Trial
Not yet recruiting·National Taipei University of Nursing and Health Sciences·Preclinical·NCT07677605·160 enrolled
Alpha Lipoic Acid in Pediatrics on Hemodialysis
Enrolling by invitation·—·Phase 3·NCT06286098·50 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)